Departamento de Medicina Preventiva - FM/MPR

O Departamento de Medicina Preventiva da Faculdade de Medicina da Universidade de São Paulo (FMUSP), criado em 1967, tem os objetivos de promover e desenvolver formas de conhecimento na área de saúde coletiva, com as especificidades que convêm a um departamento de uma escola de Medicina, por meio de ensino e pesquisa; ministrar o ensino superior, visando a formação de pessoas capacitadas ao exercício da investigação na área de saúde coletiva, bem como a qualificação para atividades profissionais; estender à sociedade serviços relacionados às atividades de ensino e pesquisa.

O Departamento desenvolve diferentes atividades em várias linhas de atuação que podem ser agrupadas nas seguintes áreas: Ciências Humanas e Sociais em Saúde, Epidemiologia, Política, Planejamento, Gestão e Avaliação em Saúde.

Site oficial: http://www2.fm.usp.br/preventiva/

Browse

Recent Submissions

  1. The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study

    SCHIZOPHRENIA RESEARCH, v.236, p.69-79, 2021

    Premorbid functioning and cognitive measures may reflect gradients of developmental impairment across diagnostic categories in psychosis. In this study, we sought to examine the associations of current cognition and premorbid adjustment with symptom dimensions in a large first episode psychosis (...

  2. Latin American cities with higher socioeconomic status are greening from a lower baseline: evidence from the SALURBAL project

    ENVIRONMENTAL RESEARCH LETTERS, v.16, n.10, article ID 104052, 10p, 2021

    The characteristics of urban green space have context-dependent associations with socioeconomic status (SES). Latin American cities provide a unique but understudied context to assess the green space-SES associations. We measured the quantity and quality of green space as greenness from satellite...

  3. Chagas disease: Performance analysis of immunodiagnostic tests anti-Trypanosoma cruzi in blood donors with inconclusive screening results

    HEMATOLOGY TRANSFUSION AND CELL THERAPY, v.43, n.4, p.410-416, 2021

    Background: The screening of Trypanosoma cruzi-infected blood donors using two serological techniques frequently leads to conflicting results. This fact prompted us to evaluate the diagnostic performance of four ""in-house"" immunodiagnostic tests and two commercially available enzyme-linked immu...

  4. Attention-deficit/hyperactivity disorder has a state-dependent association with asthma: The role of systemic inflammation in a population-based birth cohort followed from childhood to adulthood

    BRAIN BEHAVIOR AND IMMUNITY, v.97, p.239-249, 2021

    There is a high comorbidity between attention-deficit/hyperactivity disorder (ADHD) and asthma, and inflammation has been proposed as a potential pathophysiological mechanism behind this association. Most studies conducted so far have used a cross-sectional design, and none has evaluated the prev...

  5. Duration of Untreated Psychosis in First-Episode Psychosis is not Associated With Common Genetic Variants for Major Psychiatric Conditions: Results From the Multi-Center EU-GEI Study

    SCHIZOPHRENIA BULLETIN, v.47, n.6, p.1653-1662, 2021

    Duration of untreated psychosis (DUP) is associated with clinical outcomes in people with a diagnosis of first-episode psychosis (FEP), but factors associated with length of DUP are still poorly understood. Aiming to obtain insights into the possible biological impact on DUP, we report genetic an...

  6. COVID-19 and the medicines regulation challenges in times of pandemic

    CIENCIA & SAUDE COLETIVA, v.26, n.10, p.4693-4702, 2021

    The SARS-CoV-2 pandemic has brought challenges related to prevention, protection and care. Coping strategies, such as social distancing, individual protection for the population and workers, increase in the number of intensive care beds, provision of human resources and equipment are necessary ac...

  7. A Mobile Health Intervention for Patients With Depressive Symptoms: Protocol for an Economic Evaluation Alongside Two Randomized Trials in Brazil and Peru

    JMIR RESEARCH PROTOCOLS, v.10, n.10, article ID e26164, 9p, 2021

    Background: Mobile health interventions provide significant strategies for improving access to health services, offering a potential solution to reduce the mental health treatment gap. Economic evaluation of this intervention is needed to help inform local mental health policy and program develop...

  8. The satisfactory growth and development at 2 years of age of the INTERGROWTH-21st Fetal Growth Standards cohort support its appropriateness for constructing international standards

    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, v.218, n.2, suppl.S, Special Issue, p.S841-+, 2018

    BACKGROUND: The World Health Organization recommends that human growth should be monitored with the use of international standards. However, in obstetric practice, we continue to monitor fetal growth using numerous local charts or equations that are based on different populations for each body st...

  9. Development of an item pool for a questionnaire on the psychosocial consequences of hypertension labelling

    JOURNAL OF PATIENT-REPORTED OUTCOMES, v.4, n.1, article ID 2, 15p, 2019

    Background Hypertension is the most prevalent risk factor for cardiovascular disease globally. Roughly one-third of the adult population has hypertension. However, most people diagnosed with hypertension do not benefit from blood pressure control with pharmacologic interventions: they are overdia...

  10. Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis

    JOURNAL OF CLINICAL INVESTIGATION, v.131, n.22, article ID e142765, 8p, 2021

    Cutaneous leishmaniasis (CL) is caused by Leishmania donovani in Sri Lanka. Pentavalent antimonials (e.g., sodium stibogluconate [SSG]) remain first-line drugs for CL with no new effective treatments emerging. We studied whole blood and lesion transcriptomes from Sri Lankan patients with CL at pr...